ERBB2 and breast cancer: Despite lower significance, the 25.6% (n = 143) of prognostic genes that were favorable for HER2-enriched breast cancers were mainly involved in “Keratinization”, “Wnt signaling pathway” and “Vitamin D metabolism” (Supplementary Fig. 10A, lower left panel).